Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1613 1652
This examiner grants 72% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18303451 | PRODUCTION CELLS | Non-Final OA | Hoffmann-La Roche Inc. |
| 17311108 | Protein Crystal Engineering Through DNA Hybridization Interactions | Final Rejection | NORTHWESTERN UNIVERSITY |
| 18547629 | BACTERIAL DNA CYTOSINE DEAMINASES FOR MAPPING DNA METHYLATION SITES | Non-Final OA | University of Washington |
| 18560153 | COMPOSITIONS AND METHODS FOR DEBULKING VIRUS OR MICROORGANISM LOAD IN THE ORAL CAVITY | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 17792310 | CARBONIC ANHYDRASE II COMPOSITIONS AND METHODS OF USE THEREOF | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 17713220 | Enzymatic Degradation of Nylon | Final Rejection | Battelle Memorial Institute |
| 18977438 | SINGLE CELL PROTEIN WITH ENHANCED DIGESTIVE ENZYME CONTENT | Final Rejection | LanzaTech, Inc. |
| 17628908 | CLEANING AGENTS INCLUDING ENZYME | Non-Final OA | Henkel AG & Co. KGaA |
| 18290897 | QUORUM QUENCHING ENZYME, AND METHODS OF USING SAME | Non-Final OA | MIGAL GALILEE RESEARCH INSTITUTE LTD. |
| 18557895 | GDF15 MARKER PANELS FOR EARLY DETECTION OF SEPSIS | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 17613341 | METHODS AND COMPOSITIONS FOR ANAEROBIC BACTERIAL FERMENTATION | Non-Final OA | Evelo Biosciences, Inc. |
| 18469664 | SITE-SPECIFIC CLEAVAGE AND ELIMINATION OF DNA IN BACTERIAL SPECIES WITH SEGMENTED CHROMOSOMES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University Leland Stanford Junior University JUN |
| 18002184 | GOS PRE-CONDITIONING L. REUTERI AND GOS IN FINAL FORMULATION | Final Rejection | BIOGAIA AB |
| 18002163 | PRE-CONDITIONING OF L.REUTERI | Final Rejection | BIOGAIA AB |
| 18356822 | COMPOSITIONS COMPRISING A VARIANT POLYPEPTIDE AND USES THEREOF | Non-Final OA | Arbor Biotechnologies, Inc. |
| 18341502 | COMPLEX CONTAINING UNDENATURED TYPE II COLLAGEN AND CHITOSAN OLIGOSACCHARIDE, AND PREPARATION METHOD THEREFOR | Final Rejection | Ci Qu |
| 18268948 | APPLICATION OF CRISPR/CAS13 FOR THERAPY OF RNA VIRUS AND/OR BACTERIUM INDUCED DISEASES | Non-Final OA | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
| 18265891 | METHOD FOR PRODUCING A FERMENTATION PRODUCT | Non-Final OA | CALIDRIS BIO |
| 18036275 | CREATING A BIOMIMETIC VEGAN VERSION OF COLLAGEN USING PLANT-BASED AMINO ACIDS AND OPTIONAL INDUCTORS TO EMULATE THE BODY'S NATURAL COLLAGEN BUILDING PROCESS FOR NUTRACEUTICAL AND COSMECEUTICAL PURPOSES | Final Rejection | Corpowell BV |
| 17638756 | IMPROVED POLYPEPTIDES CAPABLE OF CONVERTING SUBSTRATE 3-KETO- DEOXYNIVALENOL INTO 3-EPI- DEOXYNIVALENOL | Non-Final OA | DSM Austria GmbH |
| 18044549 | RECOMBINANT ALKALINE PHOSPHATASE FOR USE IN TREATING ACUTE RESPIRATORY DISTRESS SYNDROME | Final Rejection | AM-Pharma B.V. |
| 18180633 | BASE EDITING ENZYMES | Non-Final OA | METAGENOMI, INC. |
| 17775798 | GRANULAR BACTERIA GASTROPROTECTED WITH A COATING MATRIX IN CRYSTALLINE FORM, PROCESS FOR THE PREPARATION THEREOF AND COMPOSITIONS THEREOF | Final Rejection | PROBIOTICAL S.P.A. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy